Stock Events

Notable Labs 

$0.63
6
+$0.04+7.66% Friday 19:54

Statistics

Day High
-
Day Low
-
52W High
5.27
52W Low
0.15
Volume
57,734
Avg. Volume
179,109
Mkt Cap
5.61M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

12
AUG
Earnings

Earnings

12AugExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q1 2024
Next
-4.2
-2.8
-1.41
-0.01
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NTBL. It's not an investment recommendation.
Alphabet
68918
GOOGL
Apple
60554
AAPL
Microsoft
56693
MSFT
Amazon
51850
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap18.24B
Illumina provides genomic sequencing and array-based technologies which are fundamental in personalized medicine, competing directly with Notable Labs' approach to using genetic information for cancer treatment.
Guardant Health
GH
Mkt Cap3.76B
Guardant Health specializes in blood-based cancer diagnostics, which competes with Notable Labs' focus on personalized testing to guide cancer treatment.
Fulgent Genetics
FLGT
Mkt Cap652.95M
Fulgent Genetics offers comprehensive genetic testing, directly competing with Notable Labs in the field of genetic-based cancer therapy selection.
Exact Sciences
EXAS
Mkt Cap8.64B
Exact Sciences focuses on molecular diagnostic tests, including cancer screening, which competes with Notable Labs' personalized testing for cancer treatment.
Pacific Biosciences of California
PACB
Mkt Cap452.11M
Pacific Biosciences offers sequencing systems that are used in genetically identifying cancer markers, competing with Notable Labs' approach in personalized oncology.
Adaptive Biotechnologies
ADPT
Mkt Cap595.37M
Adaptive Biotechnologies works on immune-driven medicine, including the use of genetic information to guide cancer treatment, competing with Notable Labs' methodologies.
Myriad Genetics
MYGN
Mkt Cap2.35B
Myriad Genetics focuses on molecular diagnostic tests that assess an individual's risk of developing cancer, competing with Notable Labs' personalized approach to cancer treatment.
Bionano Genomics
BNGO
Mkt Cap39.82M
Bionano Genomics provides tools for genomic analysis, including cancer research, which competes with Notable Labs' focus on using genomic data to personalize cancer therapy.

Analyst Ratings

7$Average Price Target
The highest estimate is $9.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

About

Notable Labs, Ltd., a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient is likely to respond to that specific therapeutic. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and thus fast-track clinical development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor for acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes indications; and Fosciclopirox, a pro-drug of ciclopirox for AML. Notable Labs, Ltd. is headquartered in Foster City, California.
Show more...
CEO
Dror Harats
Employees
16
Country
IL
ISIN
IL0012002452

Listings

XNAS
US
NTBL